zyclara
Generic: imiquimod
Labeler: bausch health us, llcDrug Facts
Product Profile
Brand Name
zyclara
Generic Name
imiquimod
Labeler
bausch health us, llc
Dosage Form
CREAM
Routes
Active Ingredients
imiquimod 37.5 mg/g
Manufacturer
Identifiers & Regulatory
Product NDC
99207-270
Product ID
99207-270_1216e839-274f-412d-953f-ce56f0cd42a2
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA022483
Listing Expiration
2027-12-31
Marketing Start
2011-11-28
Pharmacologic Class
Mechanism of Action
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
99207270
Hyphenated Format
99207-270
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
zyclara (source: ndc)
Generic Name
imiquimod (source: ndc)
Application Number
NDA022483 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 37.5 mg/g
Packaging
- 4 PACKET in 1 CARTON (99207-270-01) / .25 g in 1 PACKET
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["TOPICAL"], "spl_id": "1216e839-274f-412d-953f-ce56f0cd42a2", "openfda": {"nui": ["N0000009267", "N0000009269", "N0000000157"], "unii": ["P1QW714R7M"], "rxcui": ["967017", "967021"], "spl_set_id": ["28cd9b5b-680b-480f-b33d-9c5b52bbf03d"], "pharm_class_pe": ["Increased Cytokine Activity [PE]", "Increased Cytokine Production [PE]"], "pharm_class_moa": ["Interferon Inducers [MoA]"], "manufacturer_name": ["Bausch Health US, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "4 PACKET in 1 CARTON (99207-270-01) / .25 g in 1 PACKET", "package_ndc": "99207-270-01", "marketing_start_date": "20111128"}], "brand_name": "Zyclara", "product_id": "99207-270_1216e839-274f-412d-953f-ce56f0cd42a2", "dosage_form": "CREAM", "pharm_class": ["Increased Cytokine Activity [PE]", "Increased Cytokine Production [PE]", "Interferon Inducers [MoA]"], "product_ndc": "99207-270", "generic_name": "imiquimod", "labeler_name": "Bausch Health US, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Zyclara", "active_ingredients": [{"name": "IMIQUIMOD", "strength": "37.5 mg/g"}], "application_number": "NDA022483", "marketing_category": "NDA", "marketing_start_date": "20111128", "listing_expiration_date": "20271231"}